Depression and coping in adults undergoing dialysis for end‐stage renal disease

Ibrahim, Norhayati; Kong, Norella C T; Desa, Asmawati; Razali, Rosdinom

doi:10.1111/appy.12042

Cited by 33 publications

(35 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Depression was related with poorer adherence to dialysis and nutrition, poorer QoL and higher mortality rate (35). Therefore, the treatment of depression provides an additional opportunity to improve the QoL in HD patients (1).…”

Section: Discussionmentioning

confidence: 99%

Uraemic Pruritus Markedly Affects the Quality of Life and Depressive Symptoms in Haemodialysis Patients with End-stage Renal Disease

Suseł¹,

Batycka-Baran²,

Reich³

et al. 2014

Acta Derm Venerol

View full text Add to dashboard Cite

Little is known about the influence of uraemic pruritus on patients' wellbeing. The aim of our study was to evaluate the impact of uraemic pruritus on quality of life and depressive symptoms in patients with end-stage renal disease. A total of 200 haemodialysis patients were included into the study. The prevalence of uraemic pruritus was 38%. Patients with uraemic pruritus had significantly lower quality of life according to SF-36 questionnaire compared to the remaining of analysed subjects. Among patients with uraemic pruritus, 64.5% individuals also showed impaired skin-related quality of life evaluated with Dermatology Life Quality Index. The quality of life impairment correlated with uraemic pruritus intensity assessed with VAS and the 4-item itch questionnaire. Depression level significantly correlated with quality of life and severity of depressive symptoms was significantly associated with uraemic pruritus intensity. Our study underscores that uraemic pruritus should be regarded as an important health problem among haemodialysis patients.

show abstract

Section: Discussionmentioning

confidence: 99%

Uraemic Pruritus Markedly Affects the Quality of Life and Depressive Symptoms in Haemodialysis Patients with End-stage Renal Disease

Suseł¹,

Batycka-Baran²,

Reich³

et al. 2014

Acta Derm Venerol

View full text Add to dashboard Cite

show abstract

“…Depression is the most widely acknowledged psychological problem among end-stage renal disease (ESRD) patients [1,2]. About 28% of chronic kidney disease patients facing impending dialysis undergo major depression, and even a larger proportion of dialyzed patients suffer from depression [3].…”

Section: Introductionmentioning

confidence: 99%

Vitamin D status in chronic dialysis patients with depression: a prospective study

Zhang

et al. 2014

BMC Psychiatry

View full text Add to dashboard Cite

BackgroundDepression is the most widely acknowledged psychological problem among end-stage renal disease (ESRD) patients. Depression may be associated with VD deficiency. The aims of this study are to (a) elucidate the prospective association between HsCRP, VD contents and depressive symptoms in the dialyzed population, and (b) find the effect of calcitriol supplementation on depression in dialyzed patients.MethodsIn this prospective study, 484 dialysis patients (382 hemodialysis [HD] cases and 102 peritoneal dialysis [PD] cases; aged 18–60 years) from two hospitals in southeast China were included. The depression in these patients was evaluated using the Chinese version of Beck’s Depression Inventory (BDI). All subjects answered the BDI-I questionnaire for assessment of depression levels in summer. A cut-off value of 16 was set to include dialysis patients with depression. All patients were divided into two groups depending on the absence (Group1) or presence (Group 2) of depression. The two groups took 0.5 μg/day 1,25-Dihydroxyvitamin D orally for one year. BDI Scores were recalculated for all patients. Sociodemographic, clinical data, and serum VD contents were also collected.ResultsA total of 484 participants (247 men [51.0%] and 237 women [49.0%]) were surveyed. Depressive symptoms were found in 213 (44.0%) patients. The baseline serum VD level (VD2 + VD3) was 17.6 ± 7.7 nmol/L. Patients with depressive symptoms have significantly higher serum HsCRP level and significantly lower serum VD level compared with the control group. After one-year follow-up, the supplementation of 0.5 μg/day calcitriol slightly improved the microinflammatory state such as lowering mean serum HsCRP level and improving serum VD level, but not in significantly enhancing the depressive symptoms.ConclusionsCalcitriol supplementation did not significantly enhance the depressive symptoms in our dialyzed population although patients with low levels of serum VD were more depressed. Therefore, more prospective randomized controlled trials are necessary to reveal the exact cause-and-effect relationship between VD status and depressive symptoms or VD status related to some specific subtypes in dialyzed patients.

show abstract

“…Several studies have employed measures of causal attributions to assess self-blame which may not be accompanied by perceptions of control, responsibility or blame itself Friedman et al, 2007;Friedman et al, 2010;Lebel et al, 2013;Newsom et al, 1996;Plaufcan et al, 2012;Scharloo et al, 2005). Others have assessed selfblame for other aspects of the illness experience rather than its cause or onset (e.g., treatment ineffectiveness) (Aguado Loi et al, 2013;Bussell & Naus, 2010;DePalma, Rollison, & Camporese, 2011;Ibrahim, Chiew-Thong, Desa, & Razali, 2013;McSorley et al, 2014) or have measured a general tendency to experience self-blame outside of the illness context (Ali et al, 2000;Rich et al, 1999). Some have also assumed self-blame from measures that do not separate self-blame for illness onset from other related but potentially distinct constructs, such as a tendency to self-criticize or harbour feelings of guilt or shame (Condello, Piano, Dadam, Pinessi, & Lanteri-Minet, 2015;Else-Quest et al, 2009;Hommel et al, 2000;Karlsen & Bru, 2002).…”

Section: Introductionmentioning

confidence: 99%

The Relationship Between Self‐Blame for the Onset of a Chronic Physical Health Condition and Emotional Distress: A Systematic Literature Review

Callebaut

Molyneux

Alexander

2016

Clin Psychology and Psychoth

View full text Add to dashboard Cite

What does this study add? The review presents an exploration of the role of self-blame in emotional adjustment following the diagnosis of a chronic physical health condition. This is the first review to synthesize findings from studies measuring self-blame beliefs directly and specifically for illness onset and their relationship to indicators of distress and wellbeing. Findings suggest that self-blame for illness onset is often associated with emotional distress for people with cancer, HIV/AIDS and cardiovascular disease. This has implications for how healthcare professionals respond to self-blaming beliefs in the context of illness. Research quality concerns are identified for many of the reviewed studies, highlighting a need for further research on this topic.

show abstract

Depression and coping in adults undergoing dialysis for end‐stage renal disease

Cited by 33 publications

References 21 publications

Uraemic Pruritus Markedly Affects the Quality of Life and Depressive Symptoms in Haemodialysis Patients with End-stage Renal Disease

Uraemic Pruritus Markedly Affects the Quality of Life and Depressive Symptoms in Haemodialysis Patients with End-stage Renal Disease

Vitamin D status in chronic dialysis patients with depression: a prospective study

The Relationship Between Self‐Blame for the Onset of a Chronic Physical Health Condition and Emotional Distress: A Systematic Literature Review

Contact Info

Product

Resources

About